SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-012690
Filing Date
2022-05-05
Accepted
2022-05-05 16:32:40
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ngm-20220331.htm   iXBRL 10-Q 1476308
2 EX-10.1 ngm-20220331x10qex101.htm EX-10.1 43077
3 EX-31.1 ngm-20220331x10qex311.htm EX-31.1 11193
4 EX-31.2 ngm-20220331x10qex312.htm EX-31.2 10937
5 EX-32.1 ngm-20220331x10qex321.htm EX-32.1 8513
  Complete submission text file 0001628280-22-012690.txt   6357988

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngm-20220331.xsd EX-101.SCH 38160
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ngm-20220331_cal.xml EX-101.CAL 50530
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ngm-20220331_def.xml EX-101.DEF 168102
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngm-20220331_lab.xml EX-101.LAB 514895
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngm-20220331_pre.xml EX-101.PRE 324344
55 EXTRACTED XBRL INSTANCE DOCUMENT ngm-20220331_htm.xml XML 1015032
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38853 | Film No.: 22896937
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences